PAVmed (PAVM) News Today $0.49 +0.01 (+2.95%) Closing price 04:00 PM EasternExtended Trading$0.49 +0.00 (+0.61%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership AgreementOctober 7 at 8:01 AM | prnewswire.comAscendiant Capital Maintains PAVmed (PAVM) Buy RecommendationOctober 7 at 6:22 AM | msn.comPAVmed (NASDAQ:PAVM) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst SaysOctober 7 at 2:04 AM | americanbankingnews.comLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsSeptember 16, 2025 | prnewswire.comLucid Diagnostics Shares Fall After Pricing of Public Stock OfferingSeptember 11, 2025 | marketwatch.comPAVmed’s Lucid Diagnostics Completes Public Stock OfferingSeptember 11, 2025 | tipranks.comLucid Diagnostics Announces Closing of Public Offering of Common StockSeptember 11, 2025 | prnewswire.comLucid Diagnostics Announces Pricing of Public Offering of Common StockSeptember 10, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockSeptember 9, 2025 | prnewswire.comLucid Diagnostics to Host Investor Call on Monday, September 8, 2025September 5, 2025 | prnewswire.comPAVmed plans to license Duke’s oesophageal imaging technologyAugust 28, 2025 | finance.yahoo.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27, 2025 | prnewswire.comPAVmed to license esophageal imaging technology from Duke TechnologyAugust 26, 2025 | msn.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comLucid Diagnostics Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comPAVmed Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | prnewswire.comLucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comPAVmed Q2 2025 Earnings PreviewAugust 12, 2025 | msn.comLucid Diagnostics to Participate in Upcoming Investor ConferencesAugust 5, 2025 | prnewswire.comPAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025July 31, 2025 | prnewswire.comPAVmed Inc.: PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleJuly 30, 2025 | finanznachrichten.deLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025July 30, 2025 | prnewswire.comMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA TestJuly 16, 2025 | prnewswire.comPAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity FinancingJune 24, 2025 | prnewswire.comPAVmed IncJune 20, 2025 | money.usnews.comMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA TestJune 18, 2025 | prnewswire.comPAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove ...June 4, 2025 | morningstar.comMPAVmed subsidiary Veris Health partners with Ohio State University cancer centerJune 4, 2025 | finance.yahoo.comPAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteJune 3, 2025 | prnewswire.comLucid Diagnostics to Join Russell 2000® and Russell 3000® IndexesMay 27, 2025 | prnewswire.comEarnings call transcript: PAVmed’s Q1 2025 sees strong net income and strategic shiftsMay 16, 2025 | investing.comPAVmed Inc. (NASDAQ:PAVM) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comPAVmed Inc (PAVM) Q1 2025 Earnings Call Highlights: Strategic Expansion and Financial FortificationMay 16, 2025 | finance.yahoo.comPAVmed Inc. (PAVM) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comPAVmed Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | prnewswire.comPAVmed Q1 2025 Earnings PreviewMay 14, 2025 | msn.comLucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025April 30, 2025 | prnewswire.comPAVmed switches to new accounting firm post-acquisitionApril 27, 2025 | investing.comNCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERDApril 24, 2025 | prnewswire.comLucid Diagnostics Announces Closing of Public Offering of Common StockApril 11, 2025 | prnewswire.comLucid Diagnostics Shares Drop After $15M Public Offering PricedApril 10, 2025 | marketwatch.comLucid Diagnostics Announces Pricing of Public Offering of Common StockApril 9, 2025 | prnewswire.comLucid Diagnostics Announces Pricing of Public Offering of Common StockApril 9, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockApril 9, 2025 | prnewswire.comPAVmed files to sell 3.33M shares of common stock for holdersApril 8, 2025 | msn.comLucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare ConferenceApril 3, 2025 | prnewswire.comEarnings call transcript: PAVmed Q4 2024 reports net income boostMarch 27, 2025 | uk.investing.comPAVmed reports Q4 adjusted EPS (6c) vs. ($1.33) last yearMarch 27, 2025 | markets.businessinsider.comLucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection TechnologyMarch 27, 2025 | prnewswire.com Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PAVM Media Mentions By Week PAVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PAVM News Sentiment▼0.250.63▲Average Medical News Sentiment PAVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PAVM Articles This Week▼52▲PAVM Articles Average Week Get the Latest News and Ratings for PAVM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PAVmed and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Milestone Scientific News Today Precision Optics News Today Vicarious Surgical News Today Star Equity News Today NeurAxis News Today DarioHealth News Today PetVivo News Today Retractable Technologies News Today Vivos Therapeutics News Today IRIDEX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PAVM) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
